Dcgi Nod News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dcgi nod. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dcgi Nod Today - Breaking & Trending Today
May 19, 2021 The orally administered drug is being tested for treating mild and moderate infection Optimus Pharma has received the approval of the Drug Controller General of India (DCGI) to conduct Phase III clinical trials of orally administered Molnupiravir capsules on patients with mild and moderate Covid-19 infection. As per the clinical trial protocols approved, a total of 2,500 subjects in both mild and moderate Covid-19 will be randomised in the study in a 1:1 ratio to Molnupiravir with standard supportive care or standalone standard supportive care. Treatment modes The treatment duration is a maximum of five days and the total study duration will be maximum for 29 days from randomisation, the Hyderabad-based company said in a release on Wednesday. ....